These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6394358)

  • 1. [Principles, methods and criteria for assessing the effectiveness of potentially cardiotonic compounds at the preclinical research stage].
    Chekman IS; Tkachuk VV
    Farmakol Toksikol; 1984; 47(6):5-15. PubMed ID: 6394358
    [No Abstract]   [Full Text] [Related]  

  • 2. Principles of treatment of left ventricular failure.
    Taylor SH; Silke B; Nelson GI
    Eur Heart J; 1982 Dec; 3 Suppl D():19-43. PubMed ID: 6761126
    [No Abstract]   [Full Text] [Related]  

  • 3. [Protocol-guide in clinical experimentation on inotropic drugs].
    Campolo L; Padrini R; Razzolini R; Klugmann S; Chioin R
    G Ital Cardiol; 1985 Jul; 15(7):695-9. PubMed ID: 4076703
    [No Abstract]   [Full Text] [Related]  

  • 4. [The positive action of refracterin on the reserve potentials and metabolism of the myocardium during its overload in toxic-allergic myocarditis].
    Karsanov NV; Sukoian GV; Dzhibgashvili IK; Tatulashvili DR; Gorelishvili II
    Patol Fiziol Eksp Ter; 1999; (4):10-6. PubMed ID: 10636764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New positive inotropic agents.
    Jafri SM; Bristol JA
    Henry Ford Hosp Med J; 1986; 34(3):188-92. PubMed ID: 3542907
    [No Abstract]   [Full Text] [Related]  

  • 6. A phase 1-2 dose-escalating study evaluating the safety and tolerability of istaroxime and specific effects on electrocardiographic and hemodynamic parameters in patients with chronic heart failure with reduced systolic function.
    Ghali JK; Smith WB; Torre-Amione G; Haynos W; Rayburn BK; Amato A; Zhang D; Cowart D; Valentini G; Carminati P; Gheorghiade M
    Am J Cardiol; 2007 Jan; 99(2A):47A-56A. PubMed ID: 17239705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apelin has in vivo inotropic effects on normal and failing hearts.
    Berry MF; Pirolli TJ; Jayasankar V; Burdick J; Morine KJ; Gardner TJ; Woo YJ
    Circulation; 2004 Sep; 110(11 Suppl 1):II187-93. PubMed ID: 15364861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative evaluation of the effect of digoxin, strophanthin, isolanid and corglycon on the indices of central hemodynamics, vascular tonus, circulating blood volume and myocardial contractility in acute heart failure].
    Tsyganiĭ AA; Kovalev NL; Kozlovskiĭ VI; Malinovskiĭ OP; Pen'kov GI
    Anesteziol Reanimatol; 1981; (3):44-8. PubMed ID: 7294441
    [No Abstract]   [Full Text] [Related]  

  • 9. Amrinone: a promising new cardiotonic agent in the treatment of chronic cardiac failure.
    Likoff MJ; Weber KT; Andrews V; Janicki JS
    Herz; 1983 Aug; 8(4):199-205. PubMed ID: 6413341
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential alteration of cardiotonic effects of EMD 57033 and beta-adrenoceptor agonists in volume-overload rabbit ventricular myocytes.
    Sugawara H; Sakurai K; Atsumi H; Nakada S; Tomoike H; Endoh M
    J Card Fail; 2000 Dec; 6(4):338-49. PubMed ID: 11145759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inotropic effect of adrenomedullin in the isolated perfused rat heart.
    Szokodi I; Kinnunen P; Ruskoaho H
    Acta Physiol Scand; 1996 Feb; 156(2):151-2. PubMed ID: 8868273
    [No Abstract]   [Full Text] [Related]  

  • 12. [Calcium sensitizers--a new group of drugs that increase myocardium contractility].
    Laine M; Lehtonen L; Nieminen MS
    Duodecim; 2000; 116(20):2181-3. PubMed ID: 12017622
    [No Abstract]   [Full Text] [Related]  

  • 13. Digoxin in the management of cardiovascular disorders.
    Gheorghiade M; Adams KF; Colucci WS
    Circulation; 2004 Jun; 109(24):2959-64. PubMed ID: 15210613
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathomechanisms of heart failure].
    Urbaszek W
    Z Arztl Fortbild (Jena); 1993; 87(8 Suppl 4):1-4. PubMed ID: 8105608
    [No Abstract]   [Full Text] [Related]  

  • 15. Congestive cardiomyopathy: therapeutic approach.
    Chatterjee K; Stern L
    Compr Ther; 1982 Jul; 8(7):25-34. PubMed ID: 7116806
    [No Abstract]   [Full Text] [Related]  

  • 16. Inotropic agents in the critically ill.
    Cuthbertson BH; Hunter J; Webster NR
    Br J Hosp Med; 1996 Oct 16-Nov 5; 56(8):386-91. PubMed ID: 8909711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The influence of kordaron on the pharmacodynamic effects of strophanthin in experiments on isolated myocardial preparations and in the modelling of heart failure].
    Lemkina SM
    Eksp Klin Farmakol; 1993; 56(4):30-3. PubMed ID: 8220011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of calcium-sensitizing agents.
    Vegh A; Papp JG; Udvary E; Kaszala K
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S20-31. PubMed ID: 8907128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heart insufficiency: current aspects of physiopathology and therapy].
    Bolte HD
    Med Klin; 1981 Nov; 76(24):664-71. PubMed ID: 7311926
    [No Abstract]   [Full Text] [Related]  

  • 20. [The study of cardiotonic action of green frog poison Bufo viridis].
    Krylov VN
    Zh Evol Biokhim Fiziol; 2002; 38(2):173-6. PubMed ID: 12070919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.